Halozyme Therapeutics, Inc.
Technical analysis of Halozyme Therapeutics, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes proprietary enzymes and devices based on recombinant human hyaluronidase enzyme (rHuPH20) technology, which enables subcutaneous administration of biological drugs and therapeutic molecules. The company's product portfolio includes formulations for testosterone replacement therapy and subcutaneous versions of medications for treating oncological, immunological, and autoimmune diseases, developed through collaborations with international pharmaceutical partners.
Description generated automatically from public sources; it may be inaccurate or out of date.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the HALO analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Halozyme Therapeutics, Inc.
How is Halozyme Therapeutics, Inc. analysed technically?
Technical analysis of Halozyme Therapeutics, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Halozyme Therapeutics, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Halozyme Therapeutics, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Halozyme Therapeutics, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.